American Century Companies
TNGX icon

American Century Companies’s Tango Therapeutics TNGX Stock Holding History

American Century Companies’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.7M Buy
+1,013,794
New +$25.1M 0.01% 1066
2025
Q2 		– Sell
-65,146
Closed -$89.3K – 2940
2025
Q1 		$89.3K Sell
65,146
-45,302
-41% -$111K ﹤0.01% 2829
2024
Q4 		$341K Buy
110,448
+12,162
+12% +$56.5K ﹤0.01% 2641
2024
Q3 		$757K Buy
98,286
+19,590
+25% +$187K ﹤0.01% 2337
2024
Q2 		$675K Buy
78,696
+219
+0.3% +$1.69K ﹤0.01% 2330
2024
Q1 		$623K Buy
78,477
+8,068
+11% +$86.5K ﹤0.01% 2348
2023
Q4 		$697K Buy
70,409
+46,691
+197% +$405K ﹤0.01% 2227
2023
Q3 		$267K Buy
23,718
+1,826
+8% +$11.1K ﹤0.01% 2491
2023
Q2 		$72.7K Buy
21,892
+523
+2% +$1.88K ﹤0.01% 2729
2023
Q1 		$83.8K Buy
21,369
+2,888
+16% +$16.8K ﹤0.01% 2569
2022
Q4 		$134K Sell
18,481
-27,379
-60% -$193K ﹤0.01% 2413
2022
Q3 		$166K Buy
+45,860
New +$196K ﹤0.01% 2265

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

American Century Companies's TNGX Position: Q2 2026 in Review

American Century Companies opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 1,013,794 shares worth $31.7M. The stake represents 0.01% of the portfolio and ranks #1066 among its holdings. This is a return to the name: American Century Companies previously reported a position in TNGX as recently as Q1 2025.

American Century Companies first reported a position in TNGX in Q3 2022 and has held it in 12 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • American Century Companies held 1,013,794 shares of Tango Therapeutics worth $31.7M as of Q2 2026.
  • Tango Therapeutics was a new American Century Companies position in Q2 2026.
  • Tango Therapeutics made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1066 holding.
  • American Century Companies first reported a position in Tango Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.